Horizon Therapeutics Public Ltd Co Accretion Expense
Horizon Therapeutics Public Ltd Co reported Accretion Expense of $59.48 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2019-02-27
- Horizon Therapeutics Public Ltd Co accretion expense for the quarter ending 2018-12-31 was $15.11M, a 17.57% increase year-over-year.
- Horizon Therapeutics Public Ltd Co accretion expense for the quarter ending 2018-09-30 was $14.90M, a 17.10% increase year-over-year.
- Horizon Therapeutics Public Ltd Co accretion expense for the quarter ending 2018-06-30 was $14.76M, a 15.88% increase year-over-year.
- Horizon Therapeutics Public Ltd Co accretion expense for the quarter ending 2018-03-31 was $14.72M, a 13.57% increase year-over-year.
- Horizon Therapeutics Public Ltd Co accretion expense for fiscal 2018 was $59.48M, a 16.02% increase from fiscal 2017.
- Horizon Therapeutics Public Ltd Co accretion expense for fiscal 2017 was $51.26M, a 26.21% increase from fiscal 2016.
- Horizon Therapeutics Public Ltd Co accretion expense for fiscal 2016 was $40.62M, a 102.19% increase from fiscal 2015.
- Horizon Therapeutics Public Ltd Co accretion expense for fiscal 2015 was $20.09M, a 122.71% increase from fiscal 2014.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2018-12-31 | $15.11M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $30.00M derived: sum of 2 quarters · filed 2019-02-27 | $44.76M derived: sum of 3 quarters · filed 2019-02-27 | $59.48M 10-K · filed 2019-02-27 |
| 2018-09-30 | $14.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $29.65M derived: sum of 2 quarters · filed 2018-11-07 | $44.37M 10-Q · filed 2018-11-07 | $57.22M derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-06-30 | $14.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $29.48M 10-Q · filed 2018-08-08 | $42.32M derived: sum of 3 quarters · filed 2019-02-27 | $55.04M derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-03-31 | $14.72M 10-Q · filed 2018-05-09 | $27.57M derived: sum of 2 quarters · filed 2019-02-27 | $40.29M derived: sum of 3 quarters · filed 2019-02-27 | $53.02M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-12-31 | $12.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $25.57M derived: sum of 2 quarters · filed 2019-02-27 | $38.30M derived: sum of 3 quarters · filed 2019-02-27 | $51.26M 10-K · filed 2019-02-27 |
| 2017-09-30 | $12.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $25.46M derived: sum of 2 quarters · filed 2018-11-07 | $38.41M 10-Q · filed 2018-11-07 | $50.27M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $12.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $25.69M 10-Q · filed 2018-08-08 | $37.55M derived: sum of 3 quarters · filed 2019-02-27 | $47.28M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $12.96M 10-Q · filed 2018-05-09 | $24.81M derived: sum of 2 quarters · filed 2019-02-27 | $34.55M derived: sum of 3 quarters · filed 2019-02-27 | $44.22M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $11.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $21.59M derived: sum of 2 quarters · filed 2019-02-27 | $31.26M derived: sum of 3 quarters · filed 2019-02-27 | $40.62M 10-K · filed 2019-02-27 |
| 2016-09-30 | $9.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $19.40M derived: sum of 2 quarters · filed 2017-11-06 | $28.76M 10-Q · filed 2017-11-06 | $35.28M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $9.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $19.03M 10-Q · filed 2017-08-07 | $25.55M derived: sum of 3 quarters · filed 2018-02-28 | $32.09M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $9.36M 10-Q · filed 2017-05-08 | $15.88M derived: sum of 2 quarters · filed 2018-02-28 | $22.43M derived: sum of 3 quarters · filed 2018-02-28 | $26.40M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $6.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $13.07M derived: sum of 2 quarters · filed 2018-02-28 | $17.04M derived: sum of 3 quarters · filed 2018-02-28 | $20.09M 10-K · filed 2018-02-28 |
| 2015-09-30 | $6.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $10.53M derived: sum of 2 quarters · filed 2016-11-07 | $13.57M 10-Q · filed 2016-11-07 | $16.97M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $7.02M 10-Q · filed 2016-08-08 | $10.42M derived: sum of 3 quarters · filed 2017-02-27 | $13.09M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $3.04M 10-Q · filed 2016-05-09 | $6.45M derived: sum of 2 quarters · filed 2017-02-27 | $9.11M derived: sum of 3 quarters · filed 2017-02-27 | |
| 2014-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $6.07M derived: sum of 2 quarters · filed 2017-02-27 | $9.02M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $5.62M 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | $2.95M 10-Q · filed 2015-08-07 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 |